Surgical resection is the only potentially curative treatment for patients with
cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic …

Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Biliary tract cancers (BTCs) comprise a heterogenous group of aggressive and rare
malignancies arising in the bile duct outside or within the liver. BTCs include …

Cholangiocarcinoma (CCA) originates from the epithelium of the bile duct and is highly
malignant with a poor prognosis. Radical resection is the only treatment option to completely …

Adjuvant chemotherapy for cholangiocarcinoma (CCA) has not been shown to gain
significant improvements in survival. Factors contributing to suboptimal treatment response …

Cholangiocarcinoma (CCA) is a rare but devastating malignancy that presents late, and
associated with a high mortality if untreated. CCA is locally aggressive and located in close …

Klatskin's tumors, actually-redefined as perihilar cholangiocarcinoma (phCCA) do represent
50–70% of all CCAs and develop in a context of chronic inflammation and cholestasis of bile …

Background The prognosis of patients with perihilar cholangiocarcinoma have been
unsatisfactory. We established new anatomical resectability classification for patients with …

Biliary tract cancers (BTC) are a disease entity comprising diverse epithelial tumors, which
are categorized according to their anatomical location as intrahepatic (iCCA), perihilar …

Extrahepatic cholangiocarcinomas, also called bile duct carcinomas, represent a special
entity in gastrointestinal tumors, and histological specimens of the tumors are often difficult to …